About US
- HOME
- About US
Greetings from the CEO

Living bodies are made of highly delicate mechanisms. In my 30 years of working in research, I have learnt that “living organisms know best about living organisms”. This is also true in drug discovery, and direct screening in animals allows substances with efficacy to be obtained from the first attempt. However, we previously did not have the methods available to achieve this. This was the background in which Sky Pharma’s drug discovery pipeline was developed.
Profile
CEO: Hideki Ando Ph.D.
- Affiliate Professor, Tohoku University Graduate School of Dentistry (in office)
- Associate Professor, Department of Medicine, Tokyo Medical University
- Project Associate Professor, Department of Life Science and Technology, Tokyo Institute of Technology
- Research Fellow, Brain Science Institute, Institute of Physical and Chemical Research (RIKEN)
- Assistant Professor, The University of Tokyo, Department of Medicine
Company Overview
Company name | Sky Pharma Co., Ltd. |
---|---|
CEO (Founder) | Hideki Ando, Ph.D. |
Address |
[Main Office] Higashinihon Fudosan Sendai First Bldg. 1F, 6-1, Shimizukoji, Wakabayashi-ku, Sendai City, Miyagi, 984-0075, Japan [Joint Research Laboratory] Division of Oral Physiology, Department of Oral Function and Morphology, Tohoku University Graduate School of Dentistry. 4-1 Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8575, Japan [Aobayama Laboratory] Room 206, Tohoku University Cooperation Business Incubator (T-Biz), 6-6-40 Aoba, Aramaki, Aoba-ku, Sendai City, Miyagi, 980-8579, Japan |
Phone | +81-22-398-6635 |
Capital Stock | 57,000,000 JPY |
Major Shareholders |
MAKOTO Capital Co., Ltd. Digisearch and Advertising Inc. Minato Mirai Patent Firm |
Business Details | Development of regenerative medicine products |
Patent application |
Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063996* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063997* [Title] Screening method and manufacturing method for regenerative medicine of the nervous system WO 2021/201170 PCT/JP2021/014027 Japan Patent Application No. 2021-575899 [Title] Method for screening for, method for producing, and method for designing drug active ingredients https://patentscope.wipo.int/search/ja/detail.jsf?docId=WO2021201170&tab=PCTBIBLIO *Basis for an International application with a claim to priority under the Treaty of Paris. |
Address
Joint Research Laboratory
Aobayama Laboratory
Collaboration and
Partnership
Inquiries
Contact the number below for inquiries regarding collaboration and partnership with Sky Pharma Co.,Ltd.
TEL 022-398-6635
Phone +81-22-398-6635
Businesses and
Products
Inquiries
Contact the number below for inquiries regarding the businesses and products of Sky Pharma Co.,Ltd.
TEL 022-398-6635
Phone +81-22-398-6635